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G protein-coupled receptors (GPCRs) are a class of
versatile proteins that transduce signals across
membranes. Extracellular stimuli induce inter- and
intramolecular interactions that change the func-
tional state of GPCRs and activate intracellular
messenger molecules. How these interactions are
established and how they modulate the functional
state of GPCRs remain to be understood. We used
dynamic single-molecule force spectroscopy to
investigate how ligand binding modulates the energy
landscape of the human b2 adrenergic receptor
(b2AR). Five different ligands representing either
agonists, inverse agonists or neutral antagonists
established a complex network of interactions that
tuned the kinetic, energetic, and mechanical proper-
ties of functionally important structural regions of
b2AR. These interactions were specific to the effi-
cacy profile of the ligands investigated and suggest
that the functional modulation of GPCRs follows
structurally well-defined interaction patterns.
INTRODUCTION
G protein-coupled receptors (GPCRs) are a class of extraordi-
narily versatile molecules that transduce signals through cellular
membranes. They respond to light, neurotransmitters, and
hormones and are responsible for the senses of smell, taste,
and sight. GPCRs are often described as bimodal switches
that can exist in inactive and in active states. This simplified
description provides only limited explanation of their complex
functional behavior. For instance GPCRs can activate several
G protein isoforms. Furthermore, they can trigger Gprotein-inde-
pendent signaling pathways (Lefkowitz and Shenoy, 2005). Addi-
tionally, ligands that bind to GPCRs have distinct efficacy
profiles, inducing different downstream signaling pathways.
Structurally elucidating this dynamic functional behavior of
GPCRs remains challenging. Recently, crystal structures of
GPCRs in different functional states have been determined by
Choe et al. (2011), Jaakola et al. (2008), Palczewsky et al.
(2000), Rasmussen et al. (2007, 2011), Scheerer et al. (2008),Structure 20, 1391Standfuss et al. (2011), and Warne et al. (2008). They suggest
that binding of different ligands induces a variety of conforma-
tional and functional intermediates. In the unliganded state
many GPCRs exhibit basal activity. Binding of agonists triggers
a series of noncovalent intramolecular interactions, which lead
to activation of the receptor. Interactions that stabilize the basal
state of the receptor are disrupted, whereas interactions stabi-
lizing active states are established (Ghanouni et al., 2001; Rose-
nbaum et al., 2009). Different combinations of these interactions,
induced by structurally and chemically different ligands, modu-
late specific conformations that induce the functional intermedi-
ates involved in downstream signaling cascades.
GPCRs exhibiting a basal activity can activate their G protein
even in the absence of agonists. Ligands that bind to GPCRs
can either increase or decrease the basal activity, depending
on their efficacy profile (Kenakin, 2002). A broad spectrum of
ligands is available for GPCRs. Agonists are ligands that can
activate the GPCR. Full agonists lead to maximal activation of
the receptor, whereas partial agonists are not able to fully acti-
vate the GPCR, even at saturating concentrations. Inverse
agonists decrease the basal activity, and neutral antagonists
do not have any effect on the activity of the receptor. However,
antagonists block the access of other ligands to the receptor.
Depending on the ligand bound, the receptor can virtually exist
in many states between fully active and fully inactive. This variety
of ligand-specific conformational states explains the coexis-
tence of multiple functional states of the receptor (Kobilka,
2011; Kobilka and Deupi, 2007).
The human b2 adrenergic GPCR (b2AR) is one of the most
extensively studied GPCRs. Besides the a subfamily of adren-
ergic receptors (ARs), b2AR belongs to the class of A receptors
(Caron and Lefkowitz, 1993). Several crystal structures of b2AR
are available (Cherezov et al., 2007; Rasmussen et al., 2007,
2011; Rosenbaum et al., 2007, 2011). The b2 receptor mainly
resides in smooth muscles (Barnes, 1993), binds the hormones
adrenalin and noradrenalin, and is involved in regulating cardio-
vascular and pulmonary function. Several ligands that bind to
b2AR are used as drugs in cardiac disease and asthma treatment
(Bai, 1992). Investigating the interactions established by ligands
and understanding the effect of ligand binding on the dynamic
energy landscape of the receptor might help to improve the
development of more efficient drugs.
Molecular interactions of membrane proteins like b2AR can be
quantified and localized by atomic force microscopy (AFM)-
based single-molecule force spectroscopy (SMFS) (Kedrov–1402, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1391
Figure 1. SMFS of b2AR Reconstituted into
Liposomes Containing Phospholipids and
Cholesterol
(A) Pushing the AFM stylus onto the proteolipo-
somes forces the unspecific attachment of the
b2AR polypeptide to the stylus. Retraction of the
cantilever stretches the polypeptide attached to
the AFM stylus and induces the sequential
unfolding of the receptor. F, force; d, distance.
(B and C) Selection of F-D curves recorded upon
N-terminal (B, top) and C-terminal (C, top) un-
folding of b2AR. Superimpositions of 103 (B,
bottom) and 56 (C, bottom) F-D curves highlight
their common features. Red lines represent WLC
curves fitting the main force peaks with the
number on top indicating the average contour
lengths (in amino acids) revealed from the fits.
Gray scale bars allow evaluating how frequently
individual force peaks were populated.
See also Figures S1 and S2.
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Ligand-Specific Changes of b2 Adrenergic Receptorset al., 2007a). Once these interactions have been assigned
to secondary structure elements, parameters describing the
energy landscape of the membrane protein can be determined
by dynamic SMFS (DFS) (Janovjak et al., 2008). Previously,
SMFS and DFS have been applied to elucidate ligand and inhib-
itor binding to bacterial transmembrane transporters (Bippes
et al., 2009; Ge et al., 2011; Kedrov et al., 2005, 2008) and yeast
mitochondrial carriers (Kedrov et al., 2010). Here, we use SMFS
and DFS to determine interactions and energy barriers that are
established in human b2AR and change after binding of ligands
with different efficacy profiles. To ensure native-like conditions,
the receptor has been reconstituted into phospholipid liposomes
containing the cholesterol analog cholesteryl hemisuccinate
(CHS). Several ligands (three agonists, one inverse agonist,
one neutral antagonist) were tested. Changes in energetic,
kinetic, and mechanical properties of structural segments of
the receptor unravel the complexity of the interaction network
that determines the conformational and functional state of b2AR.
RESULTS
Mechanical Unfolding of Human b2AR
To determine interactions in native-like b2AR, proteoliposomes
containing b2AR were adsorbed onto freshly cleaved mica and
imaged by AFM in buffer solution (Mu¨ller and Engel, 2007). The
AFM topographs showed b2AR proteoliposomes densely
covering the supporting mica (see Figure S1 available online).
To nonspecifically attach single b2AR to theAFMstylus, the stylus
was pushed onto the proteoliposomes reaching a force of 700
pN for 0.5 s (Mu¨ller and Engel, 2007). Upon withdrawal of the
stylus, the receptor was mechanically stressed, and force-
distance (F-D) curves were recorded (Figure 1A). Principally,
b2AR could adhere to the AFM stylus with every polypeptide
loop or terminal end. Only when pulling either the N-terminal or
C-terminal end and upon unfolding b2AR into a fully stretched
conformation did the F-D curves reach maximal lengths. For
analysis, only F-D curves were selected, whose lengths corre-1392 Structure 20, 1391–1402, August 8, 2012 ª2012 Elsevier Ltd Alsponded to that of fully unfolded and stretched b2AR polypep-
tides (70–90 nm; see Experimental Procedures). About 0.5%
of 1,120,000 F-D curves showed reproducible force peak
patterns that extended over the length of a fully unfolded b2AR
molecule (Figures 1B and 1C). Although the F-D curves looked
similar, individual curves could differ to some extent from each
other. Two major classes of F-D curves were observed (Figures
1B and 1C). To highlight common force peaks among the F-D
curves, theywere superimposedandconverted intodensityplots.
Each forcepeakof aF-Dcurve represents theunfoldingof a struc-
tural segment of the receptor (Kedrov et al., 2007a). The magni-
tude of the force peak corresponds to the strength of the interac-
tion that stabilizesastructural segmentagainstunfolding.Suchan
interaction is composed of inter- and intramolecular interactions.
Unfolding b2AR from N- and C-Terminal Ends
We assumed that the two classes of F-D curves (Figures 1B and
1C) corresponded to mechanically unfolding the receptor from
the N- and C-terminal end. To assign these classes to N- or
C-terminal unfolding, theN-terminal FLAG tagwas enzymatically
removed, and the shortened b2AR was unfolded (Figure S2). A
shift of 14 aa was observed in one class of F-D curves, sug-
gesting that this particular class corresponds to N-terminal
unfolding. Approximately 75% of 5,600 F-D curves corre-
sponded to the unfolding of b2AR by mechanically pulling the
N-terminal end (Figure 1B). The remaining 25%of the F-D curves
represented unfolding the receptor from the C-terminal end
(Figure 1C). Superimpositions of F-D curves showed a character-
istic pattern of eight force peaks when unfolding b2AR from the
N-terminal end (Figure 1B). When unfolding b2AR from the
C-terminal end, only four force peaks were detected. The
C-terminal region of the receptor, which is unfolded at pulling
distances <30 nm, did not reveal reproducible unfolding events
(force peaks) (Figure 1C). Due to the low occurrence of
C-terminally pulled F-D curves that, in addition, showed less
reproducible force peaks, we focused our analysis on F-D curves
pulled from the N-terminal end.l rights reserved
Figure 2. Structural Segments Stabilizing the
Human b2AR
Secondary (A) and tertiary (B) structure model of b2AR is
shown. Each color represents a structural segment that is
stabilized by inter- and intramolecular interactions. (A)
Black amino acids highlight the end of the previous and
the beginning of the next stable structural segment. This
structural position corresponds to the mean contour
length (given in brackets) revealed from the WLC fitting of
reproducibly detected force peaks in Figure 1B. Amino
acids colored at less intensity give the SD of the average
force peak (Table S1). In case the end/beginning of
a structural segment had to be assumed to lie within the
membrane or at the membrane surface opposite to the
pulling AFM stylus, a certain number of amino acids were
added to the contour length to structurally locate the
segment (Experimental Procedures). All seven trans-
membrane a helices of b2AR are labeled H1–H7. Cyto-
plasmic and extracellular loops are indicated as C1, C2,
C3, and E1, E2, E3, respectively. H8 denotes the short
C-terminal helix 8 at the cytoplasmic side. The secondary
structural model (A) of C-terminal truncated b2AR carrying
a N-terminal FLAG epitope (blue) followed by a TEV
protease cleavage site (green) was taken fromRasmussen
et al. (2007). The tertiary structural model (B) was taken
from PDB ID 2RH1. See also Figure S3 and Table S1.
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Ligand-Specific Changes of b2 Adrenergic ReceptorsInteractions Stabilize Distinct Structural Segments
of b2AR
When exerting amechanical pulling force to a terminal end, b2AR
unfolds in sequential steps that are reflected by individual force
peaks of a F-D curve (Figure 1). Every force peak was fitted using
the worm-like chain (WLC) model (Experimental Procedures) to
reveal the contour length of the unfolded polypeptide that con-
nected AFM stylus and the unfolding intermediate of the
receptor. The contour lengths of all force peaks allowed deter-
mining all unfolding steps of b2AR (Figure 1; Table S1). An unfold-
ing step, in which a structural segment unfolds, describes theStructure 20, 1391–1402, August 8,transfer of one unfolding intermediate to the
next (Kedrov et al., 2007a). In the first unfolding
step, the N-terminal transmembrane a helix of
b2AR unfolds. After this, the polypeptide linking
the AFM stylus and b2AR is elongated and
stretched again when encountering the next
interaction stabilizing a structural segment of
the unfolding receptor. This stepwise unfolding
continues until the entire receptor unfolded.
We detected eight unfolding steps, each one
describing the unfolding of a structural segment
stabilized by the b2AR molecule. Mapped onto
the secondary structure, these stable structural
segments show where inter- and intramolecular
interactions stabilized the receptor (Figure 2).
Determining Energetic, Kinetic, and
Mechanical Properties Stabilizing b2AR
in the Absence and Presence of Ligands
The force required to unfold a structural seg-
ment reflects the strength of interactions stabi-
lizing the segment. This interaction strengthdepends on the loading rate (pulling force applied versus time)
at which the structural segment is forced to unfold (Evans,
2001). Therefore, the unfolding force gives only a relative
measure of the stability of a structure exposed to mechanical
stress. However, the free energy unfolding barrier describes
the kinetic and mechanical stability of a folded structure at equi-
librium (Figure 3A). Parameters characterizing this energy barrier
can be approximated using DFS. To reveal these parameters,
DFS determines the most probable interaction strengths that
stabilize every structural segment over a wide range of loading
rates (Evans, 2001; Janovjak et al., 2008).2012 ª2012 Elsevier Ltd All rights reserved 1393
Figure 3. Free Energy Unfolding Landscape
Describing Energetic and Kinetic Parameters of
Stable Structural Segments
(A) According to the Bell-Evans model of Evans (1998,
2001), folded structures can be characterized using
a simple two-state model. The native, folded structure
resides in an energy valley and is separated by an energy
barrier from the unfolded state. As approximated previ-
ously the surface roughness of the energy landscape of
transmembrane a helices, ε, is 4–6 kBT (Janovjak et al.,
2007). This roughness creates local energy minima that
can stabilize functionally related conformational states of
a structural segment. Thus, for a given surface rough-
ness, a wide energy valley can host more conformational
states (i.e., hosts a higher conformational variability) of
a structural segment compared to a narrow energy valley.
The transition state (z) must be overcome to induce unfolding. xu represents the distance between the folded state and the transition state, k0 is the transition
rate for crossing the energy barrier under zero force, and DGz gives the activation energy for unfolding the segment.
(B) Applying an external force (F) changes the thermal likelihood of reaching the top of the energy barrier. The energy profile along the reaction coordinate (pulling
direction) is tilted by the mechanical energy -(Fcosq)x, as indicated by the dashed line. The applied force does not change the ground-to-transition state
distance xu. q describes the angle of the externally applied force relative to the reaction coordinate. As a result of this tilt, the energy barrier separating the folded
from the unfolded state decreases, and the probability of the folded structural segment to unfold increases.
Structure
Ligand-Specific Changes of b2 Adrenergic ReceptorsWe determined the most probable unfolding force of every
structural segment at different loading rates. F-D curves were
recorded at seven pulling velocities (100, 300, 600, 900, 1,200,
2,500, and 5,000 nm/s) (Figure S4). To investigate to what extent
the binding of different ligands affects the energy landscape of
b2AR, DFS was carried out in the unbound state and in the pres-
ence of the synthetic agonists BI-167107 (BI, Boehringer Ingel-
heim) and THRX-144877 (THRX, Theravance), the natural
agonist adrenalin, the inverse agonist carazolol, and the neutral
antagonist alprenolol. For all pulling velocities superimpositions
of the F-D curves did not change drastically upon ligand binding
to b2AR (Figures S4 andS5). Next, we determined themost prob-
able unfolding force (F*) of every force peak characterizing
a stable structural segment of b2AR and plotted them for the
different loading rates (rf*) (Figure 4).
Ligands Change Energy Landscape of b2AR
As predicted by Evans (1998) and Evans and Ritchie (1997) and
experimentally verified usingmembrane proteins by Bippes et al.
(2009), Janovjak et al. (2004), Kawamura et al. (2010), Kedrov
et al. (2008), Sapra et al. (2008a, 2008b), increasing the loading
rate led to increased unfolding forces. The linear relationship
between the most probable rupture force and the logarithm of
the loading rate suggests a single energy barrier separating the
folded from unfolded state for every structural segment (Evans
and Ritchie, 1997). Fitting the DFS plots (Figure 4) using
Equation 1 revealed the distance between ground and transition
state (xu), transition rate (k0), free energy (DG
z), and mechanical
spring constant (k) of every structural segment (Figure 2). Differ-
ences between these parameters imply that the kinetic stability
and mechanical nature of molecular interactions changed in
the presence of ligands. To determine the statistical significance
of these differences, DFS plots from ligand-free and ligand-
bound b2AR were fitted simultaneously, resulting in a common
estimate for xu and k0. The sum of squares of both separate
and simultaneous fits was assessed by an F test (Table S2)
(Motulsky and Christopoulos, 2004). Several segments showed
statistically significant differences after ligand binding (Table 1).1394 Structure 20, 1391–1402, August 8, 2012 ª2012 Elsevier Ltd AlIn the following we will describe the significant differences
detected in our experiments.
Structural Segments Changing Conformational
Variability upon Ligand Binding
The distance between ground state and transition state xu
approximates the conformational variability of a structure (Fig-
ure 3) (Kumar et al., 2000). If a narrow energy valley stabilizing
a structural segment becomes wider after binding of a ligand,
the ligand increases the number of conformational states (i.e.,
conformational variability) the structural segment can adopt.
Such an effect was observed upon ligand binding to b2AR
(Table 1). Binding of agonists (BI, THRX, or adrenalin) signifi-
cantly increased the conformational variability of the core
segment [H3-C2-H4-E2-H5.1] (p < 0.001), carazolol significantly
increased the conformational variability of structural segments
[H1.2-C1] (p < 0.001), [H3-C2-H4-E2-H5.1] (p < 0.001), and
[H6.2-E3-H7-H8] (p < 0.05), whereas alprenolol significantly
increased the conformational variability of [H1.1] (p < 0.05)
(Table 1). These results show that ligand binding increases the
conformational variability (or states) of certain structural regions
of b2AR, whereas all other structural regions were not affected
significantly. It appeared that some structural regions were
modulated by different ligands, whereas other regions were
modulated by only one ligand. However, to what extent the
conformational variability of a structural region changed was
specific to the ligand.
Structural Segments Changing Lifetime upon Ligand
Binding
The transition rate k0 measures the lifetime (reciprocal of transi-
tion rate) of a structural segment. The DFS experiments (Table 1)
detected that BI, THRX, or adrenalin binding significantly
increased the lifetime of the structural segment [H3-C2-H4-E2-
H5.1] (p < 0.001), that carazolol binding significantly increased
the lifetime of the structural segments [H1.2-C1] (p < 0.001),
[H2.1] (p < 0.05), [H3-C2-H4-E2-H5.1] (p < 0.001), and [H6.2-
E3-H7-H8] (p < 0.05) and that alprenolol binding significantlyl rights reserved
Figure 4. DFS Plots Reveal Loading Rate-Dependent Interactions
Stabilizing b2AR
For each stable structural segment of b2AR, the most probable unfolding force
was plotted against the loading rate. DFS fits using Equation 1 are shown
for unliganded (red), alprenolol-bound (black), carazolol-bound (green), BI-
bound (blue), THRX-bound (orange), and adrenalin-bound (violet) states.
Values for xu and k0 obtained from fitting the DFS plots are given in Table 1.
Error bars represent the SE of most probable force and loading rate. See also
Figures S4 and S5.
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Ligand-Specific Changes of b2 Adrenergic Receptorsincreased the lifetime of the structural segment [H1.1] (p < 0.05)
(Table 1). These results demonstrate that ligand binding changes
the kinetic properties of structural regions within b2AR. However,
to what extent the kinetic properties of a structural region
changed was again specific to the ligand.
Structural SegmentsChanging FreeEnergy upon Ligand
Binding
The free energy DGz characterizes the height of the energy
barrier stabilizing a folded structure (Figure 3). DFS measure-
ments showed that ligand binding increased the free energy of
several structural segments (Table 1). BI, THRX, and adrenalin
binding significantly increased DGz of structural segment
[H3-C2-H4-E2-H5.1] (p < 0.001), carazolol significantly in-Structure 20, 1391creased DGz of structural segments [H1.2-C1] (p < 0.001),
[H2.1] (p < 0.05), [H3-C2-H4-E2-H5.1] (p < 0.001), and [H6.2-
E3-H7-H8] (p < 0.05), and alprenolol significantly increased
DGz of structural segment [H1.1] (p < 0.05).
Structural Segments Changing Mechanical Properties
upon Ligand Binding
Similar to the other parameters characterizing the energy
barriers, the k values that quantify the mechanical rigidity of
structural segments (Dietz et al., 2006) changed upon ligand
binding (Table 1). Binding of the agonists BI, THRX, and adren-
alin significantly increased the mechanical elasticity of the core
structural segment [H3-C2-H4-E2-H5.1] (p < 0.001), and alpre-
nolol significantly decreased the mechanical elasticity of struc-
tural segment [H1.1] (p < 0.05). Carazolol significantly increased
the mechanical elasticity of structural segments [H1.2-C1]
(p < 0.001), [H3-C2-H4-E2-H5.1] (p < 0.001), and [H6.2-E3-H7-
H8] (p < 0.05) and decreased that of structural segment [H2.1]
(p < 0.05). These results showed that the binding of a ligand
changed the mechanical properties of certain structural regions.
DISCUSSION
Ligand Binding to b2AR Lacks Pronounced Localized
Interactions
As for all membrane proteins investigated so far by SMFS
(Bippes and Muller, 2011), the F-D spectra recorded during
mechanical unfolding of native-like b2AR reconstituted into
proteoliposomes showed a reproducible pattern of force peaks
(Figures 1B and 1C). The reproducibility of the force peak pattern
suggests that b2AR establishes a characteristic interaction
network (Kedrov et al., 2007a). Ligand binding to the receptor
did not establish additional force peaks or significantly modify
the strength of existing force peaks (Figures S4 and S5). In
contrast, SMFS detected a significantly increased force peak
after ligand binding to functionally activated Na+/H+ antiporters
NhaA from Escherichia coli and MjHhaP1 from Methanococcus
jannaschii (Kedrov et al., 2005, 2007b). The increasing interac-
tion force was correlated to specific interactions established
between the ligand Na+ and the deprotonated aspartic acid resi-
dues at the Na+-binding site. In b2AR multiple amino acid resi-
dues from several transmembrane a helices contribute to ligand
binding (Rasmussen et al., 2011; Rosenbaum et al., 2007). Thus,
it is expected that ligand binding modulates the functional state
of b2AR by changing the interaction network in the GPCR
(Kobilka and Deupi, 2007). However, because we did not
observe drastic changes of the force peak pattern such as
observed for other membrane proteins after ligand binding (Ke-
drov et al., 2005, 2007b), we conclude that ligand binding estab-
lished rather small changes to the interactions that structurally
stabilize b2AR in the unliganded conformation.
Conformational Variability and Kinetic Stability
of Unliganded b2AR
DFS studies suggest that structural segments of bacteriorho-
dopsin, bovine and mouse rhodopsin, the antiporter NhaA, and
the transporter BetP are stabilized by single energy barriers
(Figure 3) (Ge et al., 2011; Janovjak et al., 2004; Kawamura
et al., 2010; Kedrov et al., 2008; Sapra et al., 2008c). We made–1402, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1395
Table 1. Parameters Characterizing Energy Barriers and Mechanical Spring Constants of Structural Segments Stabilizing b2AR
Stable Structural
Segment Unliganded b2AR Agonist (BI) Agonist (THRX) Agonist (Adrenalin)
Inverse Agonist
(Carazolol)
Neutral Antagonist
(Alprenolol)
xu ± SD (nm)
[H1.1] 0.44 ± 0.04 0.50 ± 0.05 0.49 ± 0.07 0.47 ± 0.05 0.45 ± 0.04 0.75 ± 0.12a
[H1.2-C1] 0.29 ± 0.02 0.27 ± 0.02 0.30 ± 0.04 0.26 ± 0.03 0.56 ± 0.07a 0.29 ± 0.02
[H2.1] 0.33 ± 0.02 0.39 ± 0.04 0.39 ± 0.05 0.33 ± 0.04 0.33 ± 0.02 0.31 ± 0.02
[H2.2-E1] 0.45 ± 0.05 0.40 ± 0.04 0.40 ± 0.06 0.54 ± 0.08 0.56 ± 0.08 0.42 ± 0.03
[H3-C2-H4-E2-H5.1] 0.55 ± 0.03 0.71 ± 0.07a 0.73 ± 0.13a 0.65 ± 0.09a 0.79 ± 0.08a 0.58 ± 0.04
[H5.2-C3-H6.1] 0.29 ± 0.02 0.23 ± 0.01 0.25 ± 0.02 0.26 ± 0.02 0.28 ± 0.02 0.27 ± 0.02
[H6.2-E3-H7-H8] 0.49 ± 0.03 0.40 ± 0.02 0.39 ± 0.05 0.40 ± 0.04 0.59 ± 0.06a 0.58 ± 0.05
[CT] 0.59 ± 0.05 0.63 ± 0.06 0.64 ± 0.10 0.49 ± 0.06 0.54 ± 0.05 0.55 ± 0.04
k0 ± SD (10
3 s1)
[H1.1] 77.3 ± 72.5 18.7 ± 22.0 43.8 ± 64.7 26.6 ± 30.5 41.5 ± 33.9 0.09 ± 0.26a
[H1.2-C1] 248 ± 178 253 ± 161 121 ± 147 473 ± 372 0.002 ± 0.005a 111 ± 76.2
[H2.1] 290 ± 174 23.1 ± 27.1 30.5 ± 42.1 234 ± 210 80.8 ± 54.8a 290 ± 179
[H2.2-E1] 166 ± 140 196 ± 144 211 ± 236 38.2 ± 55.2 6.61 ± 11.5 261 ± 155
[H3-C2-H4-E2-H5.1] 38.8 ± 22.4 0.02 ± 0.03a 0.04 ± 0.01a 1.51 ± 2.75a 0.02 ± 0.03a 13.4 ± 10.4
[H5.2-C3-H6.1] 18.0 ± 13.5 118 ± 53.3 58.3 ± 41.1 59.5 ± 41.4 16.7 ± 11.5 44.5 ± 24.8
[H6.2-E3-H7-H8] 320 ± 118 663 ± 184 480 ± 300 636 ± 329 21.9 ± 20.7a 151 ± 106
[CT] 10.7 ± 7.98 3.28 ± 3.21 2.55 ± 4.06 33.0 ± 31.2 9.99 ± 8.90 15.4 ± 10.8
DGz ± SD (kBT)
[H1.1] 21.0 ± 0.9 22.4 ± 1.2 21.5 ± 1.5 22.0 ± 1.1 21.6 ± 0.8 27.7 ± 2.7a
[H1.2-C1] 19.8 ± 0.7 19.8 ± 0.6 20.5 ± 1.2 19.2 ± 0.8 31.5 ± 2.5a 20.6 ± 0.7
[H2.1] 19.7 ± 0.6 22.2 ± 1.2 21.9 ± 1.4 19.9 ± 0.9 20.9 ± 0.7a 19.7 ± 0.6
[H2.2-E1] 20.2 ± 0.8 20.1 ± 0.7 20.0 ± 1.1 21.7 ± 1.4 23.4 ± 1.7 19.8 ± 0.6
[H3-C2-H4-E2-H5.1] 21.7 ± 0.6 29.4 ± 1.7a 28.6 ± 2.9a 24.9 ± 1.8a 29.3 ± 1.7a 22.7 ± 0.8
[H5.2-C3-H6.1] 22.4 ± 0.8 20.6 ± 0.5 21.3 ± 0.7 21.2 ± 0.7 22.5 ± 0.7 21.5 ± 0.6
[H6.2-E3-H7-H8] 19.6 ± 0.4 18.8 ± 0.3 19.2 ± 0.6 18.9 ± 0.5 22.2 ± 0.9a 20.3 ± 0.7
[CT] 23.0 ± 0.7 24.1 ± 1.0 24.4 ± 1.6 21.8 ± 0.9 23.0 ± 0.9 22.6 ± 0.7
k ± SD (N/m)
[H1.1] 0.88 ± 0.13 0.74 ± 0.12 0.76 ± 0.17 0.83 ± 0.14 0.88 ± 0.12 0.40 ± 0.09a
[H1.2-C1] 2.02 ± 0.26 2.28 ± 0.26 1.84 ± 0.39 2.30 ± 0.40 0.83 ± 0.13a 2.04 ± 0.22
[H2.1] 1.49 ± 0.18 1.22 ± 0.20 1.19 ± 0.25 1.50 ± 0.27 1.60 ± 0.16a 1.71 ± 0.20
[H2.2-E1] 0.84 ± 0.15 1.03 ± 0.15 1.04 ± 0.25 0.61 ± 0.15 0.62 ± 0.14 0.92 ± 0.10
[H3-C2-H4-E2-H5.1] 0.59 ± 0.06 0.48 ± 0.06a 0.44 ± 0.11a 0.49 ± 0.11a 0.39 ± 0.05a 0.56 ± 0.06
[H5.2-C3-H6.1] 2.23 ± 0.25 3.21 ± 0.26 2.71 ± 0.34 2.53 ± 0.33 2.45 ± 0.24 2.47 ± 0.22
[H6.2-E3-H7-H8] 0.69 ± 0.08 0.98 ± 0.09 1.03 ± 0.20 0.99 ± 0.19 0.53 ± 0.09a 0.50 ± 0.08
[CT] 0.54 ± 0.06 0.51 ± 0.07 0.49 ± 0.11 0.75 ± 0.14 0.66 ± 0.09 0.61 ± 0.07
Parameters are shown for unliganded b2AR and in the presence of two high-affinity agonists (BI and THRX), a strong partial agonist (adrenalin), an
inverse agonist (carazolol), and a neutral antagonist (alprenolol). Errors represent SDs. See also Table S1.
aStatistically significant changes to the unliganded state as assessed by F tests (Table S2).
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Ligand-Specific Changes of b2 Adrenergic Receptorsthe same observation for the structural segments of b2AR. The
transition state distance xu separating the folded from the
unfolded state of every structural segment of b2AR ranged
from 0.3 to 0.6 nm (Table 1). Thus, the structural segments of
b2AR must be stretched by 0.3–0.6 nm to induce unfolding.
These rather short distances suggest that short-ranged inter-
and intramolecular bonds, such as hydrogen bonds, van der
Waals interactions, or electrostatic interactions, had to be
ruptured to induce unfolding of the receptor. On average the
transition state distance of structural segments determined of1396 Structure 20, 1391–1402, August 8, 2012 ª2012 Elsevier Ltd Alb2AR was similar to the average values of 0.4 nm determined
for structural segments stabilizing bacteriorhodopsin, bovine
rhodopsin, and NhaA (xu ranging from 0.2 to 0.8 nm) (Janovjak
et al., 2004; Kawamura et al., 2010; Kedrov et al., 2008; Sapra
et al., 2008c). The structural segments of unliganded b2AR re-
vealed transition rates k0 between 0.011 and 0.320 s
1 (Table
1), indicating lifetimes ranging between 3 and 90 s. These
transition rates were in the range of those measured for other
membrane proteins ranging from 0.001 to 0.9 s1 (Janovjak
et al., 2004; Kawamura et al., 2010; Kedrov et al., 2008; Sapral rights reserved
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Ligand-Specific Changes of b2 Adrenergic Receptorset al., 2008c). However, the k0 values of the structural segments
of b2AR differed by a factor of 30 with structural segments [H1.1],
[H3-C2-H4-E2-H5.1], and [CT] representing the kinetically stable
regions and [H1.2-C1], [H2.1], and [H6.2-E3-H7-H8] the kineti-
cally less stable ones. Biophysical and functional studies sup-
port a multistate model of b2AR in the absence of ligands (Deupi
and Kobilka, 2010). These multiple conformational and func-
tional states observed for unliganded b2AR may be directly
related to the conformational variability and kinetic heterogeneity
of the receptor’s structural segments observed by DFS.
Energetic Stability and Mechanical Elasticity
of Unliganded b2AR
The free energy barrier DGz stabilizing the structural segments of
unliganded b2AR ranged from 20 to 23 kBT. These free energy
differences were below that determined for structural segments
of bovine rhodopsin in the inactive dark state (DGz between 20
and 28 kBT) (Table S3) and below those determined for the
structurally similar but functionally different bacteriorhodopsin
(DGz between 21 and 29 kBT) (Kawamura et al., 2010; Sapra
et al., 2008c). Thus, the structural segments of unliganded
b2AR were energetically less stable compared to those of bovine
rhodopsin and bacteriorhodopsin.
Spring constants characterizing the mechanical elasticity of
structural segments in the unliganded state varied by a factor
of four (Table 1). The intracellular end of a helix H1 together
with the first intracellular loop [H1.2-C1] (k = 2.02 N/m) and the
structural segment [H5.2-H6.1-C3] (k = 2.23 N/m) formed the
most rigid structures of the receptor. In contrast the core
segment [H3-C2-H4-E2-H5.1] (k = 0.59 N/m) and the C-terminal
domain [CT] (k = 0.54 N/m) formed the most elastic segments. In
general the structural segments stabilizing b2AR were more
elastic compared to the structural segments of bacteriorho-
dopsin, where the values for k ranged from 0.9 to 4.2 N/m (Sapra
et al., 2008c). Compared to the elasticity of the structural
segments of bovine rhodopsin (k between 0.16 and 2.54 N/m)
(Kawamura et al., 2010), the values observed for b2AR were
more similar, indicating that both class A GPCRs share consis-
tent mechanical properties (Table S3). However, the spring
constants of the structural core segments [H3-C2-H4-E2-H5.1]
of both GPCRs differed from each other. In the case of unli-
ganded b2AR, k was about four times lower than k of bovine
rhodopsin in the dark state.
High Conformational Variability and Mechanical
Elasticity of Structural Core Correlate to Basal b2AR
Activity
Parameters characterizing the energy barrier stabilizing unli-
ganded b2AR describe the receptor in its basal and low-energy
state (Kobilka and Deupi, 2007). It has been suggested that the
basal activity of b2AR in the absence of ligandsmay be attributed
to an inherent structural flexibility and tendency to adopt several
conformational states (Kobilka and Deupi, 2007). In our mea-
surements the largest segment in the receptor core [H3-C2-
H4-E2-H5.1] exposed a relatively high conformational variability
(high xu) and high mechanical elasticity (low k) compared to the
other structural segments of b2AR and compared to the core
segment of the GPCR bovine rhodopsin in the dark state. This
dark state of rhodopsin is stabilized by the covalently boundStructure 20, 1391chromophore that acts as inverse agonist and traps the GPCRs
in the inactive state (Zhukovsky and Oprian, 1989). Because the
core segment of b2AR contains multiple ligand-binding sites
(Rasmussen et al., 2011; Rosenbaum et al., 2007), the increased
conformational variability and mechanical elasticity allow the
core to sample more conformational states required to interact
with a variety of different ligands. Thus, our DFS experiments
suggest that the high conformational variability and mechanical
elasticity of the core segment (Table 1) contribute to the basal
activity of b2AR and favor ligand binding.
Properties of b2AR Modified by the Neutral Antagonist
Alprenolol
Neutral antagonists bind in the orthosteric pocket of a GPCR but
have little or no effect on basal activity. In contrast to all other
ligands tested, the neutral antagonist alprenolol only modulated
the N-terminal region of transmembrane a helix H1 ([H1.1]) and
widened the energy valley xu from 0.44 nm (unliganded) to
0.75 nm. Thus, alprenolol enhanced the conformational vari-
ability of the extracellular half of a helix H1. Furthermore, binding
of alprenolol significantly reduced the transition rate k0 and
increased the lifetime of structural segment [H1.1]. The free
energy DGz-stabilizing structural segment [H1.1] increased by
7 kBT, whereas the spring constant k decreased to 0.40 N/m
(0.88 N/m in the unliganded state). These changes show that al-
prenolol kinetically and energetically stabilizes the extracellular
part of a helix H1 and enhances its mechanical elasticity. Avail-
able crystal structures do not explain these observations. It
has been suggested that a helix H1 is involved in receptor
silencing by oligomerization (Guo et al., 2008; Liang et al.,
2003). Therefore, it may be speculated that the alprenolol-
induced kinetic and energetic stabilization as well as the struc-
tural softening of the extracellular half of a helix H1 favor oligo-
merization of the receptor.
Although the affinity of alprenolol (KD 1 nM) is comparable to
that of the agonist THRX and greater than that of adrenalin,
binding of the neutral antagonist did not show any effects on
the structural core segment [H3-C2-H4-E2-H5.1]. Thus, alpreno-
lol establishes very different interactions compared to THRX and
to other agonists (Table 1). A possible explanation for this quite
unique interaction pattern established in b2AR could be that
alprenolol has a single aromatic ring that cannot establish strong
interactions with F193 of loop E2, as shown by molecular
dynamics docking simulations by Bokoch et al. (2010). More-
over, in contrast to both agonists and carazolol, alprenolol
does not form polar interactions with serine residues from a helix
H5. This may explain that alprenolol cannot establish interac-
tions at the core segment that are supposed to change the
activity of b2AR. In summary the DFS measurements unravel
how a neutral antagonist works by simply constricting the
access of other ligands to the receptor (Kenakin, 2008) and
avoiding interactions at functionally important regions.
An Overall Scheme: Most Ligands Modulate
the Structural Core Segment of b2AR
To investigate to what extent ligands change the energetic,
kinetic, and mechanical properties of b2AR, we applied DFS in
the presence of the synthetic agonists BI and THRX, the natural
agonist adrenalin, the inverse agonist carazolol, or the neutral–1402, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1397
Figure 5. Structural Segments of b2AR Changing Properties upon
Ligand Binding
Structural segments that significantly change their energetic, kinetic, and
mechanical properties upon binding of BI, THRX, or adrenalin (A), carazolol (B),
and alprenolol (C) are highlighted (b2AR structure PDB ID code 2RH1). Arrows
denote increasing (arrow up) and decreasing (arrow down) parameters char-
acterizing the width of the energy valley (xu), transition rate (k0), energy barrier
(DGz), and spring constant (k) of stable structural segments. Trends were
taken from Table 1.
Structure
Ligand-Specific Changes of b2 Adrenergic Receptorsantagonist alprenolol. Figure 5 highlights which ligandsmodulate
the properties of different structural segments of b2AR. Binding
of both agonists and the inverse agonist carazolol significantly
modified the energetic, kinetic, and mechanical parameters of
the structural core segment [H3-C2-H4-E2-H5.1]. The magni-
tude of the effect correlates relatively well with ligand affinity,
with the lowest values being observed for the highest affinity
ligands. This may be explained by extensive interactions
between ligands and transmembrane a helices H3 and H5. As
noted above, the small effect observed for the neutral antagonist
alprenolol may be explained by the absence of polar interactions
between alprenolol and transmembrane a helix H5. In the pres-
ence of agonists and carazolol, the energy valley stabilizing the
structural core segment increased its distance to the transition
state xu from 0.55 nm (unliganded b2AR) to 0.73 nm (THRX),1398 Structure 20, 1391–1402, August 8, 2012 ª2012 Elsevier Ltd Al0.71 nm (BI), 0.65 nm (adrenalin), and 0.79 nm (carazolol). This
shift toward wider energy valleys in these ligand-bound states
implies that the core segment [H3-C2-H4-E2-H5.1] increases
conformational variability in response to ligand binding. Further-
more, the reduction of the transition rate k0 of the core segment
by several orders of magnitude suggests that this structural
region of b2AR increases lifetime by orders of magnitude in
the presence of BI, THRX, adrenalin, or carazolol. The spring
constant k of the core segment [H3-C2-H4-E2-H5.1] is slightly
reduced from 0.59 N/m (unliganded state) to 0.48 N/m (BI),
0.44 N/m (THRX), 0.49 N/m (adrenalin), and 0.39 N/m (carazolol).
This reduction in k indicates that the core segment increases
mechanical elasticity by 10%–20%. Finally, ligand binding
stabilized the b2AR core segment [H3-C2-H4-E2-H5.1] by
increasing free energy DGz by 7.7 kBT (BI), 6.9 kBT (THRX), 3.2
kBT (adrenalin), and 7.6 kBT (carazolol), compared to unliganded
b2AR. Thus, the high-affinity ligands BI, THRX, and carazolol
increased the free energy stabilizing the core segment twice as
much compared to the natural agonist adrenalin.
Structural and functional data suggest that the core segment
[H3-C2-H4-E2-H5.1] is important for ligand binding and b2AR
activation:
(1) Several amino acid residues of transmembrane a helices
H3 and H5 are part of the ligand-binding pocket (Gether
et al., 2002). For instance H3 and H5.1 establish polar
interactions and hydrophobic contacts with BI (Rasmus-
sen et al., 2011). Two residues of H3, D113 and V114,
contribute to agonist binding (Rasmussen et al., 2011).
Furthermore, S203 of H5.1 is crucial for agonist binding,
as shown by mutagenesis studies by Liapakis et al.
(2000).
(2) Receptor activation by agonists involves disruption of the
ionic lock, which links the cytoplasmic parts of a helices
H3 and H6 in the inactive state (Ballesteros et al., 2001).
(3) The second intracellular loop C2 is important for the
efficiency of G protein activation and contains a switch
that enables G protein coupling (Wess, 1997).
In summary DFS detected that binding of agonists and the
inverse agonist carazolol increases structural flexibility, ener-
getic stability, and lifetime (kinetic stability) of the functionally
important core segment [H3-C2-H4-E2-H5.1]. These altered
properties of the core segment enable b2AR to adopt more
conformations from which certain conformations are supposed
to represent an active state.
The affinities of the agonists investigated range from a KD of
0.84 pM (BI) to a KD of 3.68 mM (adrenalin). KD of THRX is
1 nM. Each agonist changed the conformational variability,
kinetic stability, energetic stability, and mechanical elasticity of
the structural core segment [H3-C2-H4-E2-H5.1] differently. A
systematic relation may be found between the kinetic stability
of [H3-C2-H4-E2-H5.1], which increased with increasing affinity
of the agonists that bound to b2AR. However, it should be noted
that binding of agonists alone is insufficient to stabilize b2AR in
the active state (Kobilka, 2011). Even binding of full agonists
cannot stabilize every b2AR in the active state (Yao et al.,
2009). The reason for this apparent discrepancy is that although
bound to a ligand, the probability of b2ARs to adopt otherl rights reserved
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Deupi, 2007). Interestingly, the active state can be further stabi-
lized through interactions with G proteins or camelid antibodies
(nanobodies) that exhibit G protein-like behavior (Kobilka,
2011; Rasmussen et al., 2011). Characterizing such stable
b2AR/G protein complexes using DFS may be useful to quantify
the conformational variability, kinetic stability, energetic stability,
and mechanical elasticity of the structural core segment [H3-
C2-H4-E2-H5.1] in the fully active state.
The Inverse Agonist Carazolol Introduces Major
Modifications to b2AR
Among all ligands tested, carazolol modulated the properties
of most structural segments of b2AR. Besides changing the
energetic, kinetic, and mechanical properties of the core seg-
ment [H3-C2-H4-E2-H5.1] such as observed for the agonists,
carazolol significantly affected three other structural segments:
[H1.2-C1], [H2.1], and [H6.2-E3-H7-H8] (Table 1). Carazolol
widened the energy valley stabilizing [H1.2-C1], [H3-C2-H4-E2-
H5.1], and [H6.2-E3-H7-H8] by 0.10–0.27 nm. This indicates
that these segments enhanced their conformational variability.
Furthermore, carazolol reduced the transition rate k0 and, thus,
increased the lifetime of each of the four structural segments
by up to six orders of magnitude. The free energy DGz of struc-
tural segments [H1.2-C1] and [H3-C2-H4-E2-H5.1] increased
by 10 kBT. Carazolol slightly lowered the spring constants k
of structural segments [H2.1], [H3-C2-H4-E2-H5.1], and [H6.2-
E3-H7-H8], thereby increasing their structural elasticity. The
strongest effect was observed for the structural segment
[H1.2-C1], where k reduced from 2.02 N/m in the unliganded
state to 0.83 N/m in the carazolol-bound state.
Several amino acid residues of a helices H3, H5, H6, and H7
are important for carazolol binding (Rosenbaum et al., 2007).
For instance W109, V114, and V117 of a helix H3 establish
hydrophobic contacts with carazolol. Additionally, polar interac-
tions between carazolol andD113 of a helix H3 aswell as S203 of
H5.1 are crucial for carazolol binding. Furthermore, hydrophobic
contacts between W286, F289, and F290 of a helix H6 and car-
azolol contribute to binding of the inverse agonist (Cherezov
et al., 2007; Rasmussen et al., 2007). Moreover, loop E2 of the
structural segment [H3-C2-H4-E2-H5.1] establishes a salt
bridge with extracellular loop E3 in the inactive state (Bokoch
et al., 2010). Carazolol stabilizes packing interactions involving
I121 (H3), P211 (H5.1), F282 (H6.2), and N318 (H7) that
contribute to a network of interactions that stabilize an inactive
conformation of the receptor (Kobilka, 2011). Thus, from this
point it may not be surprising that we detect that the structural
segments [H3-C2-H4-E2-H5.1] and [H6.2-E3-H7-H8] change
their properties upon carazolol binding. However, DFS quantifies
to what extent the properties of these and other structural
regions change.
Carazolol Modifies Structural Regions Proposed
to Be Involved in Oligomerization
Inverse agonists promote higher-order b2AR oligomerization that
alters access to other signaling proteins (Fung et al., 2009). The
significant changes of the energy barriers (xu, k0, and DG
z) and
spring constants (k) characterizing the structural segments
[H1.2-C1], [H3-C2-H4-E2-H5.1], and [H6.2-E3-H7-H8] in theStructure 20, 1391presence of carazolol are of particular interest because they
significantly increase conformational variability, mechanical flex-
ibility, kinetic stability, and energetic stability upon carazolol
binding. It has been proposed for several other class A GPCRs
that oligomerization involves primarily the interface between
a helices H1 and H8 (Guo et al., 2008; Liang et al., 2003). Thus,
all structural segments changing their properties may contribute
to the oligomerization of b2AR. Particularly a helices H4 and H5
are involved in the native packing arrangement of rhodopsin
and define the rhodopsin dimer (Liang et al., 2003). It is therefore
likely that the increased conformational variability of the core
segment [H3-C2-H4-E2-H5.1] contributes to the formation of
dimers and higher-ordered oligomers in the presence of carazo-
lol. Conversely, interactions between protomers changing their
oligomeric state can influence the parameters quantified by
DFS (Sapra et al., 2006a). Thus, we cannot distinguish whether
changes of the structural segments are induced by carazolol
binding or carazolol-induced oligomerization.
Carazolol Employs Direct and Indirect Interactions
to Modify Structural Regions
Although carazolol binds to b2ARwith picomolar affinity (compa-
rable to BI), it significantly changed the energy landscape of four
structural segments. The effect of carazolol on the energy land-
scape of the receptor is more pronounced compared to the
effects caused by any of the other agonists or the neutral antag-
onist investigated. Not all of the structural segments are
supposed to interact directly with carazolol (Rosenbaum et al.,
2007). Thus, we conclude that carazolol binding changes the
properties of the structural regions of b2AR by direct interactions
and by indirect interactions, which do not result from directly
contacting the ligand.
Conclusions
Energy landscapes describe conformational variability, kinetic
stability, energetic stability, and mechanical elasticity of proteins
(Janovjak et al., 2008). GPCRs adopt many different conforma-
tions that are closely related to functional states (Kobilka and
Deupi, 2007). Our work contributes to a more detailed under-
standing of the energetic, kinetic, and mechanical properties of
native-like b2ARs reconstituted into membranes of phospho-
lipids and cholesterol. We observed that the interactions of unli-
ganded b2AR stabilize well-defined structural segments of the
receptor. In the presence of a ligand, SMFS could not detect
drastic changes of these interactions, and the stabilizing struc-
tural segments did not change positions. Thus, it can be
concluded that ligand binding to b2AR induces rather weak inter-
actions instead of strong localized interactions. However, DFS
showed that the interactions established upon ligand binding
were sufficient to change the conformational, energetic, kinetic,
and mechanical properties of structural segments of b2AR.
Agonist or inverse agonist binding increased the conforma-
tional variability, kinetic stability, energetic stability, and me-
chanical elasticity of the functionally important structural core
segment [H3-C2-H4-E2-H5.1] of b2AR. To what extent individual
ligands could change the properties of the core segment was
intrinsic to the ligand. In contrast to the agonists (BI, THRX,
and adrenalin), the inverse agonist carazolol affected, in addition
to the core segment, three structural segments: [H1.2-C1],–1402, August 8, 2012 ª2012 Elsevier Ltd All rights reserved 1399
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Ligand-Specific Changes of b2 Adrenergic Receptors[H2.1], and [H6.2-E3-H7-H8]. Finally, the neutral antagonist
alprenolol changed only the properties of structural segment
[H1.1]. The functionally important structural core segment of
the receptor remained unaffected by alprenolol.
Taken together, our single-molecule experiments reveal that
ligands establish interactions that modulate the properties of
distinct structural segments within b2AR. Quantifying the ener-
getic, kinetic, and mechanical parameters of the structural
segments provides insight into how these structural segments
stabilize ligand-specific conformations of the receptor. Depend-
ing on which structural segments change their energetic, kinetic,
or mechanical properties, the receptor samples more active
states in the presence of agonists or more inactive states in
the presence of the inverse agonist.
EXPERIMENTAL PROCEDURES
Cloning, Purification, Overexpression, and Reconstitution of b2AR
Sf9 insect cells were grown at 27C in suspension cultures in ESF-921medium
(Expression Systems, USA) supplemented with 0.5 mg/ml gentamicin. The
Bac-to-Bac Baculovirus Expression System (Invitrogen, USA) was used for
generating baculovirus for the b2AR. We used a modified construct of human
b2AR with a truncated C-terminal end (48 aa) and a N-terminal FLAG epitope
followed by a TEV protease cleavage site (Figure 2). b2AR expression was
accomplished by infecting Sf9 cells at a density of 3 3 106 cells/ml for
48 hr. Cells expressing receptors, as assessed by immunofluorescence,
were harvested by centrifugation (15min at 5,0003 g). Cell pellets were stored
at80C. From these pellets b2AR was purified using a three-step purification
procedure as described by Fung et al. (2009). For preparation of lipids, 1,2-di-
oleoyl-sn-glycero-3-phosphocholine (DOPC) (Avanti Polar Lipids, USA) and
the cholesterol analog CHS (Steraloids, USA) were mixed and dissolved in
chloroform to form a stock solution of lipids at concentrations of 20 and
10 mg/ml. DOPC and CHS were added to a glass vial, with DOPC at a
10-fold excess, and the chloroform was evaporated under a fine stream of
argon. The lipids were then dried under vacuum for 1 hr. After this, the lipids
were resuspended in 100 mM NaCl, 1% (w/v) octylclucoside, 20 mM HEPES
(pH 7.5), vortexed, and sonicated for 1 hr in an ice water bath. The lipid mixture
was stored at80C. b2ARwas reconstituted as described previously by Fung
et al. (2009). Briefly, 300 ml samples were prepared containing lipid and the
b2AR at a lipid-to-receptor ratio of 1,000:1 (mol:mol). The lipid/receptor
mixture was mixed with reconstitution buffer (100 mM NaCl, 20 mM HEPES
[pH 7.5]) at a final volume of 300 ml and placed on ice for 2 hr. Vesicles were
formed removing detergent on a Sephadex G-50 (fine) column (25 3 0.8 cm)
using reconstitution buffer. To bind ligands, b2AR was preincubated for 1 hr
at room temperature (22C) with saturating amounts of ligand: 10 mM for
BI, THRX, and carazolol, 100 mM for alprenolol, and 100 mM for adrenalin.
During subsequent reconstitution steps the same concentration of ligand
was included in the reconstitution buffer.
SMFS and DFS
SMFS was conducted using two different AFMs that provided similar results:
ForceRobot 300 (JPK Instruments, Germany) and Nanoscope IIIa PicoForce
AFM (Bruker, Germany). SMFS data of b2AR were recorded at pulling veloci-
ties of 100, 300, 600, 900, 1,200, 2,500, and 5,000 nm/s. SMFS at pulling
velocity of 5,000 nm/s was recorded using a 16 bit data acquisition hardware
(Nanoscope IIIa: NI PCI-6221; ForceRobot 300: NI PCI-6251, National Instru-
ments, Germany). Cantilevers used (60 mm long silicon nitride A-BioLever,
BL-RC150 VB, Olympus, Japan) had nominal resonance frequencies of 8
kHz in water. Cantilever spring constants (30 pN/nm) were determined in
buffer solution using the equipartition theorem by Butt and Jaschke (1995)
prior to experiments. Due to uncertainties in calibrating the cantilever spring
constant (10%), b2AR was unfolded using at least five different cantilevers
for each velocity. Proteoliposomes containing b2AR were adsorbed over night
at 4C onto freshly cleaved mica in SMFS buffer (300 mMNaCl, 25 mMMgCl2,
25 mM Tris [pH 7.0]). Mica is an atomically flat, chemically inert, and hydro-
philic surface that, so far, did not significantly influence the structure-function1400 Structure 20, 1391–1402, August 8, 2012 ª2012 Elsevier Ltd Alrelationship of membrane proteins and their interactions probed by SMFS
(Mu¨ller and Engel, 2007). To remove weakly attached membrane patches,
the sample was rinsed several times with SMFS buffer. SMFS buffer solutions
were prepared using nanopure water (18 MOhm/cm; PURE-LAB Ultras, ELGA
LabWater) and pro-analysis grade chemicals from Sigma-Aldrich or Merck. To
characterize ligand binding, SMFS buffer was supplemented with adequate
amounts of the ligand. Unfolding events were monitored recording the
cantilever deflection and the distance separating cantilever stylus and
membrane. Interaction forces were calculated from the cantilever deflection
using Hook’s law.
Data Selection
Mechanical unfolding of b2ARwas recorded by F-D curves. Each force peak of
a F-D curve denoted the rupture of an unfolding barrier established by a struc-
tural segment of b2AR. The distance at which a force peak was detected as-
signed the contour length of the unfolded and stretched polypeptide that teth-
ered the AFM stylus and the anchoring structural segment. The very last force
peak of a F-D curve represented the unfolding of the last structural segment
remaining anchored by themembrane bilayer (Mu¨ller et al., 2002). Overcoming
the stability of this last segment led to complete unfolding of the receptor,
followed by extraction from the membrane. In the GPCR bovine rhodopsin,
the last structural segment (or unfolding barrier) corresponds to helix H8, which
lies parallel to the membrane bilayer followed by a palmitoylation site (Sapra
et al., 2006b). We assumed that this was also the case for b2AR because it
shares very similar structural features with rhodopsin. A fully stretched b2AR
polypeptide that remains anchored by helix H8 would show a contour length
of 260 to 290 aa. Therefore, F-D curves showing a maximum length of
70–90 nm (260–290 aa) were selected for data analysis.
Data Analysis
Every force peak of a F-D curve was fitted using the WLC model by Busta-
mante et al. (1994):
FðxÞ= kBT
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: (Equation 1)
A persistence length (P) of 0.4 nm and a backbone length of 0.36 nm were
assumed for every amino acid. The contour length (L) (in amino acids) obtained
from fitting a force peak using theWLCmodel describes the length of the poly-
peptide that had been unfolded and stretched. Contour lengths and rupture
forces were statistically analyzed for every reproducibly occurring force
peak using built-in and custom procedures of IgorPro 6 (WaveMetrics, USA).
To superimpose F-D curves, they were aligned at the characteristic force
peak detected at a contour length of 121 aa.
Assignment of Stable Structural Segments
The contour length determined byWLC fitting corresponds to the length of the
unfolded and stretched b2AR polypeptide that tethers AFM stylus and a struc-
tural unfolding intermediate. Thus, every force peak could be used to assign
the end of the previous and the beginning of the following structural segment
that stabilized b2AR against unfolding (Kedrov et al., 2007a). Some stable
structural segments had to be assumed to begin at the cytoplasmic b2AR
surface at the opposite side of the pulling AFM stylus. To locate the beginning
of such a stable structural segment, the thickness of the membrane (4 nm)
was added to the contour length of the corresponding force peak (Kedrov
et al., 2007a). Accordingly, 11 aa (11 aa 3 0.36 nm/aa) was added to the
contour length of a force peak. If the beginning of a stable structural segment
was located within themembrane, less amino acids were added to the contour
length.
Calculation of xu and k0
The Bell-Evans theory by Evans (1998) describes the most probable unfolding
force (F*) as a function of the most probable loading rate (rf*) to reveal insight
into the unfolding energy barrier that stabilizes a structural segment against
unfolding (Evans and Ritchie, 1997). The relation between F* and rf* can be
described by:
F =
kBT
xu
ln

xur

f
kBTk0

: (Equation 2)l rights reserved
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probable loading rate, xu the distance between the free energy minimum
and the transition state, and k0 the unfolding rate at zero applied force. Using
a nonlinear least-squares algorithm, the parameters xu and k0 were obtained
by fitting Equation 1 to a DFS plot (Figure 4). The loading rate was calculated
using rf = kspacer v, where kspacer is the spring constant of the stretched poly-
peptide and v the pulling velocity. kspacer corresponds to the slope of a force
peak before rupture. Experimental force and loading rate histograms were
fitted using Gaussian distributions.
Calculation of Transition Barrier Height and Mechanical Spring
Constant
The free energy barrier DGz separating the unfolded from the folded state was
calculated using the Arrhenius equation:
D Gz =  kBT ln ðtDk0Þ: (Equation 3)
tD is the diffuse relaxation time (Dietz and Rief, 2004) and is typically in
a range between 107 and 109 s (Krieger et al., 2003). We used a tD of
108 s in our calculations. Varying tD in the aforementioned range would
change DGz by <15%. Furthermore, the influence of errors of tD would be
the same for all conditions and DGz values, even if tD was wrong by orders
of magnitude. Errors in DGz were calculated by propagation of errors of k0.
Without having information on the energy potential shape, we assumed
a simple parabolic potential and calculated the mechanical spring constant
k of a structural segment using DGz and xu (Dietz et al., 2006) with the following
equation:
k=
2 D Gz
x2u
: (Equation 4)
To estimate errors in k, errors in DGz and xu were propagated.
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